SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2311BCRX down 24% -- no real news that I could see...mopgcw-4/2/2009
2310Tom ya, maybe there's more there than meets the eye. But from what I see anfred hayes-4/1/2009
2309I lost a buck interpreting the announcement as no big deal. Most people seem to tom pope-4/1/2009
2308celg off 16 percent on what looks like not-such-a-big-deal earnings guidance redfred hayes-4/1/2009
2307ARIA off 20% on >4X daily volume ARIA-Q Volume exceeds 50-day average volumIan@SI-3/31/2009
2306ACOR off %22 on news of refusal to file. Has recovered to off %18tnsaf-3/31/2009
2305Arna off 22%, on meeting study goals: Arena obesity drug meets study goals ArenRockyBalboa-3/30/2009
2304OSIR--Osiris Discontinues Enrollment in Crohn's Study Due to Concerns with Tkenhott-3/27/2009
2303Cytos vaccine fails mid-stage trial, shares slump By Katie Reid ZURICH, March 1nigel bates-3/17/2009
2302Looks to me that the fear of FDA not approving because of the absence of any comhmpa-3/16/2009
2301ARNA off 18% on Canaccord Rumor-mongering. It's almost as if the market thIan@SI-3/16/2009
2300UTHR on sale today Heavy stock, scratched $55, off $12 pre hours. Will trade belRockyBalboa-3/16/2009
2299Reneuron 45%, as they place 100m shares at 3p.nigel bates-3/12/2009
2298CYTX -24% on news: "Cytori Therapeutics to Raise $10 Million in Registered tnsaf-3/10/2009
2297Another merger! Merck buying..mlkr-3/9/2009
2296HGSI down more than 40 % on Phase III results.sjemmeri-3/9/2009
2295Very useful, I have a bit to learn in this space. I am staying away, as these eBiotech Jim13/6/2009
2294NVS has acquired Mycograb (with NeuTec) - a human recombinant antibody against fidos-3/6/2009
2293Forgot Serenex, macked by Pfizer last year. Novartis also has a program. So fatuck-3/6/2009
2292Yup, on the solid medical need. But this isn't being given orally, even thotuck-3/6/2009
2291You folks that follow SNTA, do you follow the HSP90 blocker program and is the pBiotech Jim-3/6/2009
2290Synta (SNTA), having rebounded to over $3 briefly, is off 17% to the low $2s. Ctuck-3/5/2009
2289<i>What´s wrong?</i> Other than the market and the economy? PThe Dodgy Ticker33/2/2009
2288What´s wrong?RockyBalboa-3/2/2009
2287>> Without significant short interest it is difficult to keep a stock liquscaram(o)uche-3/2/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News